ArticleBMJ public health2024
Perspectives of healthcare providers and persons with type 2 diabetes mellitus on improving glycaemic control in Kinshasa, Democratic Republic of the Congo: a qualitative study.
Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Urinary concentration levels and health risk assessment of phthalates, parabens, benzophenone-3, bisphenols and triclosan in the adult population of Kinshasa: a cross-sectional study in Democratic Republic of Congo (DRC).Archives of public health = Archives belges de sante publique · 2026Article
- Type 2 diabetes in the Democratic Republic of Congo: an urgent need for a management framework.Health promotion international · 2023Article
- Perspectives for glycaemic control in type 2 diabetes in Kinshasa, Democratic Republic of the Congo.Health promotion international · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Glycaemic control remains suboptimal in the Democratic Republic of the Congo. Defining interventions to improve glycaemic control requires a clear knowledge of factors driving poor glycaemic control. Qualitative studies exploring the perspectives of key stakeholders on this issue are lacking in the Democratic Republic of the Congo. This study aimed to explore the perspectives of persons with type 2 diabetes and healthcare providers on ways to improve glycaemic control in Kinshasa, Democratic Republic of the Congo. Methods: This qualitative study used face-to-face, semistructured interviews on 26 purposively sampled participants: 10 persons with type 2 diabetes and 16 healthcare providers. The study used deductive, constructionist and thematic analyses. Themes were organised and integrated using the WHO Innovative Care for Chronic Conditions Framework. Results: The healthcare providers recommended better preparation of the healthcare system for better care of diabetes. This is achieved through training of healthcare providers, equipping healthcare structures and organising a reliable drug delivery system. Healthcare providers must also act to ensure that patients get adequate support from their surroundings and the community by providing adequate information about diabetes. The policy environment must create conditions for alleviating the cost of care and prevention of diabetes. In addition, patients with diabetes identified three needs: need mainly for financial support to overcome the cost of diabetes, knowledge for better self-management of the illness and support from healthcare providers to succeed in self-management. Conclusion: Improving glycaemic control in persons with type 2 diabetes requires multidimensional strategies, with particular focus on empowering patients and their families for efficient self-management, strengthening the healthcare system for diabetes care and greater involvement of the government in terms of funding and adopting positive policies. To be efficient, these interventions need to be integrated into the chronic diseases management framework.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.